HuMab, a leading Genome Engineering company based out of South Korea, was founded in the year 2018. The company develops SynTheseTM, a transgenic antibody platform, by leveraging its cutting edge genome engineering technology. SynTheseTM is revolutionary and powerful and can produce human...